These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 8400270)
1. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox. Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270 [TBL] [Abstract][Full Text] [Related]
2. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease. Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684 [TBL] [Abstract][Full Text] [Related]
3. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity. Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587 [TBL] [Abstract][Full Text] [Related]
4. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037 [TBL] [Abstract][Full Text] [Related]
5. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478 [TBL] [Abstract][Full Text] [Related]
6. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox. Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis in three cases of X91- variant chronic granulomatous disease. Bu-Ghanim HN; Segal AW; Keep NH; Casimir CM Blood; 1995 Nov; 86(9):3575-82. PubMed ID: 7579466 [TBL] [Abstract][Full Text] [Related]
8. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase. Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399 [TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system. Condino-Neto A; Newburger PE Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826 [TBL] [Abstract][Full Text] [Related]
10. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143 [TBL] [Abstract][Full Text] [Related]
11. CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease. Li F; Linton GF; Sekhsaria S; Whiting-Theobald N; Katkin JP; Gallin JI; Malech HL Blood; 1994 Jul; 84(1):53-8. PubMed ID: 7517218 [TBL] [Abstract][Full Text] [Related]
12. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Azuma H; Oomi H; Sasaki K; Kawabata I; Sakaino T; Koyano S; Suzutani T; Nunoi H; Okuno A Blood; 1995 Jun; 85(11):3274-7. PubMed ID: 7756659 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant. Yu L; Cross AR; Zhen L; Dinauer MC Blood; 1999 Oct; 94(7):2497-504. PubMed ID: 10498623 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. Dusi S; Nadalini KA; Donini M; Zentilin L; Wientjes FB; Roos D; Giacca M; Rossi F J Immunol; 1998 Nov; 161(9):4968-74. PubMed ID: 9794433 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. Newburger PE; Skalnik DG; Hopkins PJ; Eklund EA; Curnutte JT J Clin Invest; 1994 Sep; 94(3):1205-11. PubMed ID: 8083361 [TBL] [Abstract][Full Text] [Related]
17. The arachidonate-activable, NADPH oxidase-associated H+ channel. Evidence that gp91-phox functions as an essential part of the channel. Henderson LM; Banting G; Chappell JB J Biol Chem; 1995 Mar; 270(11):5909-16. PubMed ID: 7890722 [TBL] [Abstract][Full Text] [Related]
18. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis. Porter CD; Kuribayashi F; Parkar MH; Roos D; Kinnon C Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):571-5. PubMed ID: 8615831 [TBL] [Abstract][Full Text] [Related]
19. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation. Anderson-Cohen M; Holland SM; Kuhns DB; Fleisher TA; Ding L; Brenner S; Malech HL; Roesler J Clin Immunol; 2003 Dec; 109(3):308-17. PubMed ID: 14697745 [TBL] [Abstract][Full Text] [Related]